Should You Worry About the Latest Wave of Bad News from Pfizer?

Earlier in the pandemic, Pfizer (PFE 1.91%) stood out as an earnings and stock-market star thanks to its leading coronavirus vaccine and treatment. But these days, those products are weighing on growth -- and pushing some investors to flee the stock. That's because, as we head toward a…#pfe #pfizer #seagen
Source: Reuters: Health - Category: Consumer Health News Source Type: news